Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Drying of Pigment-Cellulose Nanofibril Substrates.
Timofeev O, Torvinen K, Sievänen J, Kaljunen T, Kouko J, Ketoja JA. Timofeev O, et al. Materials (Basel). 2014 Oct 1;7(10):6893-6907. doi: 10.3390/ma7106893. Materials (Basel). 2014. PMID: 28788220 Free PMC article.
Enhancing oncogenic signaling to kill cancer cells.
Noeparast M, Timofeev O, Pichler M. Noeparast M, et al. Among authors: timofeev o. Trends Pharmacol Sci. 2024 May 10:S0165-6147(24)00091-9. doi: 10.1016/j.tips.2024.04.011. Online ahead of print. Trends Pharmacol Sci. 2024. PMID: 38734500 Free article.
Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferase.
Merle N, Elmshäuser S, Strassheimer F, Wanzel M, König AM, Funk J, Neumann M, Kochhan K, Helmprobst F, Pagenstecher A, Nist A, Mernberger M, Schneider A, Braun T, Borggrefe T, Savai R, Timofeev O, Stiewe T. Merle N, et al. Among authors: timofeev o. Mol Cancer. 2022 Oct 3;21(1):191. doi: 10.1186/s12943-022-01661-2. Mol Cancer. 2022. PMID: 36192757 Free PMC article.
Partial p53 reactivation is sufficient to induce cancer regression.
Klimovich B, Meyer L, Merle N, Neumann M, König AM, Ananikidis N, Keber CU, Elmshäuser S, Timofeev O, Stiewe T. Klimovich B, et al. Among authors: timofeev o. J Exp Clin Cancer Res. 2022 Mar 2;41(1):80. doi: 10.1186/s13046-022-02269-6. J Exp Clin Cancer Res. 2022. PMID: 35232479 Free PMC article.
p53 partial loss-of-function mutations sensitize to chemotherapy.
Klimovich B, Merle N, Neumann M, Elmshäuser S, Nist A, Mernberger M, Kazdal D, Stenzinger A, Timofeev O, Stiewe T. Klimovich B, et al. Among authors: timofeev o. Oncogene. 2022 Feb;41(7):1011-1023. doi: 10.1038/s41388-021-02141-5. Epub 2021 Dec 14. Oncogene. 2022. PMID: 34907344 Free PMC article.
29 results